Montpellier University Hospital
Montpellier, France
NCT Number: NCT04301596
The main theme of the cohort of systemic sclerosis (SSc) patients is the determination of nutritional status, its evolution and the evaluation of its management in patients with scleroderma.
The main objectives are :
* To determine the incidence of malnutrition and its main determinants (disease characteristics, severity, eating habits, physical activity) in patients with scleroderma. * For patients with undernutrition at inclusion or at 18 months follow-up:
evaluate the impact of a standardized nutritional intervention (dietary advice, oral supplements, artificial, enteral or parenteral nutrition) on nutritional and disease parameters.
Follow-up visits will take place every 6 months for 2 years. (M6, M12, M18 et M24).
During each visit: a clinical examination, with anthropometric measurements, a 3-day dietary survey and a blood sample (10 ml), completion a multiple-choice of quality of life and physical activity evaluation.
Paraclinical evaluation : echocardiography, lung function tests, screening for osteoporosis (M6 and M18).
If undernutrition is detected during a follow-up visit, the subject will be referred to a specialized service.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Montpellier, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
different set of data will be collected over a 6 months period
Time frame: 6 months
Incidence of malnutrition will be measured as a loss of more than 10% of body weight or a body mass index (BMI) less than 21 kg/m2
Time frame: 6 months
Collection of data related to SSc disease burden
Time frame: 6 months
body weight gain > 5%
University Hospital, Montpellier
Other
Assessment of Nutritional Status in Systemic Sclerosis: Prospective Cohort Study in Montpellier University Hospital
Acronym: NUTRISCLER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07012655
Connective Tissue Diseases, Scleroderma, Systemic
Asyut, Egypt
View Trial DetailsNCT01395732
Connective Tissue Diseases, Digital Ulcers
Amsterdam, Netherlands
View Trial DetailsNCT04995588
Connective Tissue Diseases, Scleroderma, Systemic
Poitiers, France
View Trial DetailsNCT02562079
Connective Tissue Diseases, Scleroderma, Systemic
Bordeaux, France
View Trial Details